{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:10:15Z","timestamp":1788444615991,"version":"build-2803163510"},"reference-count":62,"publisher":"Bentham Science Publishers Ltd.","issue":"26","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Cancer continues to be the second leading cause of death worldwide, with\ncolorectal cancer (CRC) being the third most common type. Despite significant advances in cancer\ntherapies, the current treatment of CRC remains suboptimal. In addition, the effectiveness of available\nchemotherapeutic drugs such as 5-Fluorouracil (5-FU) is limited by CRC-acquired resistance.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>In this study, we provide innovative approaches employed in synthesizing four novel nucleobase\nanalogs. Equally, we describe the effects of these compounds on proliferation, migration,\naggregation, and adhesion of 5-FU-sensitive (HCT116) and -resistant (5-FU-R-HCT116) human\nCRC cells. In either cell type, our synthesized novel analogs significantly inhibited cell viability in\na concentration- and time-dependent manner. This highlights the higher potency of these novel\nanalogs. In addition, these compounds attenuated migration and adhesion of both cell types while\nthey promoted homotypic cell-cell interaction.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>These changes were reflected by the downregulation of matrix metalloproteases (MMP-2\nand MMP-9). Furthermore, our analogs exhibited potent anti-angiogenic activity in vivo.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>These novel nucleobase analogs reduced the level of secreted vascular endothelial\ngrowth factor (VEGF) and nitric oxide (NO) production in both 5-FU-sensitive and -resistant CRC\ncells. Taken together, our data highlight the potential chemotherapeutic properties of our novel\nanalogs against CRC, including the 5-FU-resistant form.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867329666220914112042","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T11:35:09Z","timestamp":1663328109000},"page":"3032-3049","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["2-Nucleobase-substituted 4,6-Diaminotriazine Analogs: Synthesis and\nAnti-cancer Activity in 5-Fluorouracil-sensitive and Resistant Colorectal\nCancer Cells"],"prefix":"10.2174","volume":"30","author":[{"given":"Khalil","family":"Hamze","sequence":"first","affiliation":[{"name":"Department of Chemistry, American University of Beirut, P.O. Box 11-0236, 1107-2020, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rola H.","family":"Abdallah","sequence":"additional","affiliation":[{"name":"Department of Biology,\nAmerican University of Beirut, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nour K","family":"Younis","sequence":"additional","affiliation":[{"name":"Brigham and Women\u2019s Hospital-Harvard Medical School, Boston, MA02115,\nUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manal","family":"Fardoun","sequence":"additional","affiliation":[{"name":"Department of Biology, American University of Beirut, P.O. Box 11-0236, 1107-2020, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine","family":"Darwiche","sequence":"additional","affiliation":[{"name":"Department of Biochemistry\nand Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, 1107-2020, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firas","family":"Kobeissy","sequence":"additional","affiliation":[{"name":"Department of Biochemistry\nand Molecular Genetics, Faculty of Medicine, American University of Beirut, P.O. Box 11-0236, 1107-2020, Beirut, Lebanon"},{"name":"Department of Emergency Medicine, University of Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabah","family":"Iratni","sequence":"additional","affiliation":[{"name":"Department of Biology, College of Science, United Arab\nEmirates University, Al-Ain, P.O. Box17551, UAE"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Bouhadir","sequence":"additional","affiliation":[{"name":"Department of Chemistry, American University of Beirut, P.O. Box 11-0236, 1107-2020, Beirut, Lebanon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, College of Medicine, QU Health, Qatar\nUniversity, Doha, P.O. Box2713, Qatar"},{"name":"Biomedical and Pharmaceutical Research Unit, QU Health, Qatar University, Doha, P.O.\nBox2713, Qatar"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"World Health Organization cancer. Available from: 2018 [Accessed on: Dec 1, 2018]."},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1046\/j.1365-2648.2003.02584.x-i1","volume":"44","author":"Rassool G.H.","year":"2003","unstructured":"Rassool G.H.; Global cancer rates could increase by 50% to 15 million by 2020. J Adv Nurs 2003,44(1),7-8","journal-title":"J Adv Nurs"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clcc.2014.11.002","volume":"14","author":"Gustavsson B.","year":"2015","unstructured":"Gustavsson B.; Carlsson G.; Machover D.; Petrelli N.; Roth A.; Schmoll H.J.; Tveit K.M.; Gibson F.; A review of the evolution of systemic chemotherapy in the management of colorectal cancer. Clin Colorectal Cancer 2015,14(1),1-10","journal-title":"Clin Colorectal Cancer"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","volume":"24","author":"McQuade R.M.","year":"2017","unstructured":"McQuade R.M.; Stojanovska V.; Bornstein J.C.; Nurgali K.; Colorectal cancer chemotherapy: The evolution of treatment and new approaches. Curr Med Chem 2017,24(15),1537-1557","journal-title":"Curr Med Chem"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1038\/bjc.2011.449","volume":"105","author":"Bose D.","year":"2011","unstructured":"Bose D.; Zimmerman L.J.; Pierobon M.; Petricoin E.; Tozzi F.; Parikh A.; Fan F.; Dallas N.; Xia L.; Gaur P.; Samuel S.; Liebler D.C.; Ellis L.M.; Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells. Br J Cancer 2011,105(11),1759-1767","journal-title":"Br J Cancer"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1517\/17425247.4.5.513","volume":"4","author":"Diab R.","year":"2007","unstructured":"Diab R.; Degobert G.; Hamoudeh M.; Dumontet C.; Fessi H.; Nucleoside analogue delivery systems in cancer therapy. Expert Opin Drug Deliv 2007,4(5),513-531","journal-title":"Expert Opin Drug Deliv"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1470-2045(02)00788-X","volume":"3","author":"Galmarini C.M.","year":"2002","unstructured":"Galmarini C.M.; Mackey J.R.; Dumontet C.; Nucleoside analogues and nucleobases in cancer treatment. Lancet Oncol 2002,3(7),415-424","journal-title":"Lancet Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2880","DOI":"10.1021\/cr900028p","volume":"109","author":"Parker W.B.","year":"2009","unstructured":"Parker W.B.; Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem Rev 2009,109(7),2880-2893","journal-title":"Chem Rev"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"9063","DOI":"10.1038\/sj.onc.1207229","volume":"22","author":"Sampath D.","year":"2003","unstructured":"Sampath D.; Rao V.A.; Plunkett W.; Mechanisms of apoptosis induction by nucleoside analogs. Oncogene 2003,22(56),9063-9074","journal-title":"Oncogene"},{"key":"ref=10","first-page":"21","volume":"19","author":"Plunkett W.","year":"2001","unstructured":"Plunkett W.; Gandhi V.; Purine and pyrimidine nucleoside analogs. Cancer Chemother Biol Response Modif 2001,19,21-45","journal-title":"Cancer Chemother Biol Response Modif"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/nrc1074","volume":"3","author":"Longley D.B.","year":"2003","unstructured":"Longley D.B.; Harkin D.P.; Johnston P.G.; 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003,3(5),330-338","journal-title":"Nat Rev Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","volume":"206","author":"Vodenkova S.","year":"2020","unstructured":"Vodenkova S.; Buchler T.; Cervena K.; Veskrnova V.; Vodicka P.; Vymetalkova V.; 5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future. Pharmacol Ther 2020,206,107447","journal-title":"Pharmacol Ther"},{"key":"ref=13","first-page":"S18-13","volume":"24","author":"Bertino J.R.","year":"1997","unstructured":"Bertino J.R.; Chemotherapy of colorectal cancer: History and new themes. Semin Oncol 1997,24(5 Suppl 18),S18-13-s18-17","journal-title":"Semin Oncol"},{"key":"ref=14","year":"2018","unstructured":"The American Cancer Society How Chemotherapy Drugs WorkAvailable from:  [Accessed on: Dec 1, 2018].2018"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2174\/1568026615666150915111933","volume":"16","author":"Burke M.P.","year":"2016","unstructured":"Burke M.P.; Borland K.M.; Litosh V.A.; Base-modified nucleosides as chemotherapeutic agents: Past and future. Curr Top Med Chem 2016,16(11),1231-1241","journal-title":"Curr Top Med Chem"},{"key":"ref=16","first-page":"39","volume":"8","author":"Abdel-Samad R.","year":"2018","unstructured":"Abdel-Samad R.; Aouad P.; Gali-Muhtasib H.; Sweidan Z.; Hmadi R.; Kadara H.; D\u2019Andrea E.L.; Fucci A.; Pisano C.; Darwiche N.; Mechanism of action of the atypical retinoid ST1926 in colorectal cancer: DNA damage and DNA polymerase \u03b1. Am J Cancer Res 2018,8(1),39-55","journal-title":"Am J Cancer Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2017\/4134093","volume":"2017","author":"Fardoun M.","year":"2017","unstructured":"Fardoun M.; Al-Shehabi T.; El-Yazbi A.; Issa K.; Zouein F.; Maaliki D.; Iratni R.; Eid A.H.; \nZiziphus nummularia Inhibits Inflammation-Induced Atherogenic Phenotype of Human Aortic Smooth Muscle Cells. Oxid Med Cell Longev 2017,2017,1-10","journal-title":"Oxid Med Cell Longev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1021\/acs.jmedchem.5b00608","volume":"59","author":"Karabanovich G.","year":"2016","unstructured":"Karabanovich G.; Zemanov\u00e1 J.; Smutn\u00fd T.; Sz\u00e9kely R.; \u0160arkan M.; Cent\u00e1rov\u00e1 I.; Vocat A.; P\u00e1vkov\u00e1 I.; \u010conka P.; N\u011bme\u010dek J.; Stola\u0159\u00edkov\u00e1 J.; Vejsov\u00e1 M.; V\u00e1vrov\u00e1 K.; Klime\u0161ov\u00e1 V.; Hrab\u00e1lek A.; P\u00e1vek P.; Cole S.T.; Miku\u0161ov\u00e1 K.; Roh J.; Development of 3,5-dinitrobenzylsulfanyl-1,3,4-oxadiazoles and thiadiazoles as selective antitubercular agents active against replicating and nonreplicating mycobacterium tuberculosis. J Med Chem 2016,59(6),2362-2380","journal-title":"J Med Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.bmcl.2015.12.042","volume":"26","author":"Bouhadir K.H.","year":"2016","unstructured":"Bouhadir K.H.; Koubeissi A.; Mohsen F.A.; El-Harakeh M.D.; Cheaib R.; Younes J.; Azzi G.; Eid A.A.; Novel carbocyclic nucleoside analogs suppress glomerular mesangial cells proliferation and matrix protein accumulation through ROS-dependent mechanism in the diabetic milieu. II. Acylhydrazone-functionalized pyrimidines. Bioorg Med Chem Lett 2016,26(3),1020-1024","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1021\/jo01345a028","volume":"31","author":"Lira E.P.","year":"1966","unstructured":"Lira E.P.; Huffman C.W.; Some Michael-Type Reactions with Adenine. J Org Chem 1966,31(7),2188-2191","journal-title":"J Org Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/j.1742-4658.2010.07919.x","volume":"278","author":"Gialeli C.","year":"2011","unstructured":"Gialeli C.; Theocharis A.D.; Karamanos N.K.; Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J 2011,278(1),16-27","journal-title":"FEBS J"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/ijms21082773","volume":"21","author":"Pranteda A.","year":"2020","unstructured":"Pranteda A.; Piastra V.; Stramucci L.; Fratantonio D.; Bossi G.; The p38 MAPKsignaling activation in colorectal cancer upon therapeutic treatments. Int J Mol Sci 2020,21(8),2773","journal-title":"Int J Mol Sci"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2174\/138161210790232149","volume":"16","author":"Hickok J.","year":"2010","unstructured":"Hickok J.; Thomas D.; Nitric oxide and cancer therapy: the emperor has NO clothes. Curr Pharm Des 2010,16(4),381-391","journal-title":"Curr Pharm Des"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3322\/caac.21601","volume":"70","author":"Siegel R.L.","year":"2020","unstructured":"Siegel R.L.; Miller K.D.; Goding Sauer A.; Fedewa S.A.; Butterly L.F.; Anderson J.C.; Cercek A.; Smith R.A.; Jemal A.; Colorectal cancer statistics, 2020. CA Cancer J Clin 2020,70(3),145-164","journal-title":"CA Cancer J Clin"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1111\/jcmm.12531","volume":"19","author":"Kugimiya N.","year":"2015","unstructured":"Kugimiya N.; Nishimoto A.; Hosoyama T.; Ueno K.; Enoki T.; Li T.S.; Hamano K.; The c-MYC-ABCB5 axis plays a pivotal role in 5-fluorouracil resistance in human colon cancer cells. J Cell Mol Med 2015,19(7),1569-1581","journal-title":"J Cell Mol Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1158\/1541-7786.MCR-19-0436","volume":"17","author":"Zhang S.","year":"2019","unstructured":"Zhang S.; Chatterjee T.; Godoy C.; Wu L.; Liu Q.J.; Carmon K.S.; GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism. Mol Cancer Res 2019,17(11),2196-2207","journal-title":"Mol Cancer Res"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41419-022-04599-x","volume":"13","author":"Wang Z.","year":"2022","unstructured":"Wang Z.; Li Y.; Mao R.; Zhang Y.; Wen J.; Liu Q.; Liu Y.; Zhang T.; DNAJB8 in small extracellular vesicles promotes Oxaliplatin resistance through TP53\/MDR1 pathway in colon cancer. Cell Death Dis 2022,13(2),151","journal-title":"Cell Death Dis"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.18632\/oncotarget.22890","volume":"9","author":"Bhardwaj M.","year":"2018","unstructured":"Bhardwaj M.; Cho H.J.; Paul S.; Jakhar R.; Khan I.; Lee S.J.; Kim B.Y.; Krishnan M.; Khaket T.P.; Lee H.G.; Kang S.C.; Vitexin induces apoptosis by suppressing autophagy in multi-drug resistant colorectal cancer cells. Oncotarget 2018,9(3),3278-3291","journal-title":"Oncotarget"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/0005-2736(76)90160-7","volume":"455","author":"Juliano R.L.","year":"1976","unstructured":"Juliano R.L.; Ling V.; A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta Biomembr 1976,455(1),152-162","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0092-8674(86)90595-7","volume":"47","author":"Chen C.","year":"1986","unstructured":"Chen C.; Chin J.E.; Ueda K.; Clark D.P.; Pastan I.; Gottesman M.M.; Roninson I.B.; Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 1986,47(3),381-389","journal-title":"Cell"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/PGP.0b013e31829c677f","volume":"33","author":"Volpicelli E.R.","year":"2014","unstructured":"Volpicelli E.R.; Lezcano C.; Zhan Q.; Girouard S.D.; Kindelberger D.W.; Frank M.H.; Frank N.Y.; Crum C.P.; Murphy G.F.; The multidrug-resistance transporter ABCB5 is expressed in human placenta. Int J Gynecol Pathol 2014,33(1),45-51","journal-title":"Int J Gynecol Pathol"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/s41419-019-1611-4","volume":"10","author":"Ndreshkjana B.","year":"2019","unstructured":"Ndreshkjana B.; \u00c7apci A.; Klein V.; Chanvorachote P.; Muenzner J.K.; Huebner K.; Steinmann S.; Erlenbach-Wuensch K.; Geppert C.I.; Agaimy A.; Ballout F.; El-Baba C.; Gali-Muhtasib H.; Roehe A.V.; Hartmann A.; Tsogoeva S.B.; Schneider-Stock R.; Combination of 5-fluorouracil and thymoquinone targets stem cell gene signature in colorectal cancer cells. Cell Death Dis 2019,10(6),379","journal-title":"Cell Death Dis"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.3390\/ijms20215510","volume":"20","author":"Pedrosa P.","year":"2019","unstructured":"Pedrosa P.; Corvo M.L.; Ferreira-Silva M.; Martins P.; Carvalheiro M.C.; Costa P.M.; Martins C.; Martins L.M.D.R.S.; Baptista P.V.; Fernandes A.R.; Targeting cancer resistance via multifunctional gold nanoparticles. Int J Mol Sci 2019,20(21),5510","journal-title":"Int J Mol Sci"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"110571","DOI":"10.1016\/j.colsurfb.2019.110571","volume":"185","author":"Thorat N.D.","year":"2020","unstructured":"Thorat N.D.; Bauer J.; Tofail S.A.M.; Gasc\u00f3n P\u00e9rez V.; Bohara R.A.; Yadav H.M.; Silica nano supra-assembly for the targeted delivery of therapeutic cargo to overcome chemoresistance in cancer. Colloids Surf B Biointerfaces 2020,185,110571","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref=35","first-page":"2789","volume":"9","author":"Shen C.J.","year":"2019","unstructured":"Shen C.J.; Lin P.L.; Lin H.C.; Cheng Y.W.; Huang H.S.; Lee H.; RV-59 suppresses cytoplasmic Nrf2-mediated 5-fluorouracil resistance and tumor growth in colorectal cancer. Am J Cancer Res 2019,9(12),2789-2796","journal-title":"Am J Cancer Res"},{"key":"ref=36","author":"Adwan H.","year":"2018","unstructured":"Adwan H.; Elharouni D.; Habashy D.; Banna N.; Georges R.; Pervaiz A.; Berger M.; Early Metastasis in Colorectal Cancer Poses an Option for New Diagnostic and Treatment Strategies in: Cancer metastatis; Intech Open: london 2018"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/10533","volume":"5","author":"Sebolt-Leopold J.S.","year":"1999","unstructured":"Sebolt-Leopold J.S.; Dudley D.T.; Herrera R.; Becelaere K.V.; Wiland A.; Gowan R.C.; Tecle H.; Barrett S.D.; Bridges A.; Przybranowski S.; Leopold W.R.; Saltiel A.R.; Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med 1999,5(7),810-816","journal-title":"Nat Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/sj.onc.1202367","volume":"18","author":"Hoshino R.","year":"1999","unstructured":"Hoshino R.; Chatani Y.; Yamori T.; Tsuruo T.; Oka H.; Yoshida O.; Shimada Y.; Ari-i S.; Wada H.; Fujimoto J.; Kohno M.; Constitutive activation of the 41-\/43-kDa mitogen-activated protein kinase signaling pathway in human tumors. Oncogene 1999,18(3),813-822","journal-title":"Oncogene"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.2147\/OTT.S241367","volume":"13","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Deng G.; Fu Y.; Han Y.; Guo C.; Yin L.; Cai C.; Shen H.; Wu S.; Zeng S.; FOXC2 Promotes Oxaliplatin Resistance by Inducing Epithelial-Mesenchymal Transition via MAPK\/ERK Signaling in Colorectal Cancer. OncoTargets Ther 2020,13,1625-1635","journal-title":"OncoTargets Ther"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1002\/jcp.29361","volume":"235","author":"Huang L.","year":"2020","unstructured":"Huang L.; Chen S.; Fan H.; Ai F.; Sheng W.; BZW2 promotes the malignant progression of colorectal cancer via activating the ERK\/MAPK pathway. J Cell Physiol 2020,235(5),4834-4842","journal-title":"J Cell Physiol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0076-6879(07)00429-6","volume":"439","author":"Vinot S.","year":"2008","unstructured":"Vinot S.; Anguille C.; de Toledo M.; Gadea G.; Roux P.; Analysis of cell migration and its regulation by Rho GTPases and p53 in a three-dimensional environment. Methods Enzymol 2008,439,413-424","journal-title":"Methods Enzymol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/1471-2407-8-58","volume":"8","author":"Lin T.H.","year":"2008","unstructured":"Lin T.H.; Kuo H.C.; Chou F.P.; Lu F.J.; Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide. BMC Cancer 2008,8(1),58","journal-title":"BMC Cancer"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/carcin\/bgl203","volume":"28","author":"Park J.M.","year":"2006","unstructured":"Park J.M.; Kim A.; Oh J.H.; Chung A.S.; Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF- B activation. Carcinogenesis 2006,28(4),837-847","journal-title":"Carcinogenesis"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1046\/j.1440-1827.2002.01343.x","volume":"52","author":"Nabeshima K.","year":"2002","unstructured":"Nabeshima K.; Inoue T.; Shimao Y.; Sameshima T.; Matrix metalloproteinases in tumor invasion: Role for cell migration. Pathol Int 2002,52(4),255-264","journal-title":"Pathol Int"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3390\/cancers6010366","volume":"6","author":"Said A.","year":"2014","unstructured":"Said A.; Raufman J.P.; Xie G.; The role of matrix metalloproteinases in colorectal cancer. Cancers (Basel) 2014,6(1),366-375","journal-title":"Cancers (Basel)"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/jcmm.12450","volume":"19","author":"Dai F.","year":"2015","unstructured":"Dai F.; Chen Y.; Huang L.; Wang J.; Zhang T.; Li J.; Tong W.; Liu M.; Yi Z.; A novel synthetic small molecule  -306 suppresses colorectal tumour growth and metastasis via  pathway. J Cell Mol Med 2015,19(2),383-395","journal-title":"J Cell Mol Med"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1158\/0008-5472.CAN-14-3534","volume":"75","author":"Saias L.","year":"2015","unstructured":"Saias L.; Gomes A.; Cazales M.; Ducommun B.; Lobjois V.; Cell\u2013Cell Adhesion and Cytoskeleton Tension Oppose Each Other in Regulating Tumor Cell Aggregation. Cancer Res 2015,75(12),2426-2433","journal-title":"Cancer Res"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"jcs.183699","DOI":"10.1242\/jcs.183699","volume":"129","author":"Mui K.L.","year":"2016","unstructured":"Mui K.L.; Chen C.S.; Assoian R.K.; The mechanical regulation of integrin\u2013cadherin crosstalk organizes cells, signaling and forces. J Cell Sci 2016,129(6),jcs.183699","journal-title":"J Cell Sci"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1242\/jcs.100115","volume":"126","author":"Canel M.","year":"2013","unstructured":"Canel M.; Serrels A.; Frame M.C.; Brunton V.G.; E-cadherin\u2013integrin crosstalk in cancer invasion and metastasis. J Cell Sci 2013,126(2),393-401","journal-title":"J Cell Sci"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1242\/jcs.064618","volume":"124","author":"Weber G.F.","year":"2011","unstructured":"Weber G.F.; Bjerke M.A.; DeSimone D.W.; Integrins and cadherins join forces to form adhesive networks. J Cell Sci 2011,124(8),1183-1193","journal-title":"J Cell Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"32622","DOI":"10.18632\/oncotarget.5327","volume":"6","author":"Ahn J.Y.","year":"2015","unstructured":"Ahn J.Y.; Lee J.S.; Min H.Y.; Lee H.Y.; Acquired resistance to 5-fluorouracil via HSP90\/Src-mediated increase in thymidylate synthase expression in colon cancer. Oncotarget 2015,6(32),32622-32633","journal-title":"Oncotarget"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.3390\/jcm8122115","volume":"8","author":"Gasiul\u0117 S.","year":"2019","unstructured":"Gasiul\u0117 S.; Dreize N.; Kaupinis A.; Ra\u017eanskas R.; \u010ciupas L.; Stankevi\u010dius V.; Kapustina \u017d.; Laurinavi\u010dius A.; Valius M.; Vilkaitis G.; Molecular insights into mirna-driven resistance to 5-fluorouracil and oxaliplatin chemotherapy: miR-23b modulates the epithelial\u2013mesenchymal transition of colorectal cancer cells. J Clin Med 2019,8(12),2115","journal-title":"J Clin Med"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/molecules21070965","volume":"21","author":"Du B.","year":"2016","unstructured":"Du B.; Shim J.; Targeting epithelial\u2013mesenchymal transition (EMT) to overcome drug resistance in cancer. Molecules 2016,21(7),965","journal-title":"Molecules"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/cancers10020052","volume":"10","author":"Roche J.","year":"2018","unstructured":"Roche J.; Theepithelial-to-mesenchymal transition in cancer. Cancers (Basel) 2018,10(2),52","journal-title":"Cancers (Basel)"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1159\/000488301","volume":"41","author":"Seeber A.","year":"2018","unstructured":"Seeber A.; Gunsilius E.; Gastl G.; Pircher A.; Anti-angiogenics: Their value in colorectal cancer therapy. Oncol Res Treat 2018,41(4),188-193","journal-title":"Oncol Res Treat"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1002\/ijc.26179","volume":"129","author":"Hasan M.R.","year":"2011","unstructured":"Hasan M.R.; Ho S.H.Y.; Owen D.A.; Tai I.T.; Inhibition of VEGF induces cellular senescence in colorectal cancer cells. Int J Cancer 2011,129(9),2115-2123","journal-title":"Int J Cancer"},{"key":"ref=57","first-page":"7913","volume":"8","author":"Qiu Y-Y.","year":"2015","unstructured":"Qiu Y-Y.; Hu S-J.; Bao Y-J.; Liang B.; Yan C-N.; Shi X-J.; Yu H.; Zou Y.; Tang L-R.; Tang Q-F.; Feng W.; Yin P-H.; Anti-angiogenic and anti-proliferative effects of inhibition of HIF-1\u03b1 by p-HIF-1\u03b1 RNAi in colorectal cancer. Int J Clin Exp Pathol 2015,8(7),7913-7920","journal-title":"Int J Clin Exp Pathol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ccr.2005.12.021","volume":"9","author":"Mavria G.","year":"2006","unstructured":"Mavria G.; Vercoulen Y.; Yeo M.; Paterson H.; Karasarides M.; Marais R.; Bird D.; Marshall C.J.; ERK-MAPK signaling opposes Rho-kinase to promote endothelial cell survival and sprouting during angiogenesis. Cancer Cell 2006,9(1),33-44","journal-title":"Cancer Cell"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41419-018-1010-2","volume":"9","author":"Xu Z.","year":"2018","unstructured":"Xu Z.; Zhu C.; Chen C.; Zong Y.; Feng H.; Liu D.; Feng W.; Zhao J.; Lu A.; CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met\/ERK\/ Elk-1\/HIF-1\u03b1\/VEGF-A pathway in colorectal cancer. Cell Death Dis 2018,9(10),974","journal-title":"Cell Death Dis"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.bcp.2017.10.011","volume":"149","author":"Ol\u00e1h G.","year":"2018","unstructured":"Ol\u00e1h G.; M\u00f3dis K.; T\u00f6r\u00f6 G.; Hellmich M.R.; Szczesny B.; Szabo C.; Role of endogenous and exogenous nitric oxide, carbon monoxide and hydrogen sulfide in HCT116 colon cancer cell proliferation. Biochem Pharmacol 2018,149,186-204","journal-title":"Biochem Pharmacol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.niox.2018.12.008","volume":"83","author":"Gao Y.","year":"2019","unstructured":"Gao Y.; Zhou S.; Xu Y.; Sheng S.; Qian S.Y.; Huo X.; Nitric oxide synthase inhibitors 1400W and L-NIO inhibit angiogenesis pathway of colorectal cancer. Nitric Oxide 2019,83,33-39","journal-title":"Nitric Oxide"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.3892\/mmr.2013.1704","volume":"8","author":"Zhou Q.","year":"2013","unstructured":"Zhou Q.; Qi C.L.; Li Y.; He X.D.; Li J.C.; Zhang Q.Q.; Tian L.; Zhang M.; Han Z.; Wang H.; Yang X.; Wang L.J.; A novel four-step system for screening angiogenesis inhibitors. Mol Med Rep 2013,8(6),1734-1740","journal-title":"Mol Med Rep"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220914112042","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/208816\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867329666220914112042","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:59:59Z","timestamp":1693684799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/208816\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":62,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867329666220914112042","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-02-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-04-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}